Report · Oct 5, 2026
Same Weed, Two Different Laws: Rescheduling Explained for Jersey
Medical weed in New Jersey is federally Schedule III now. Rec weed from the same shelf is still Schedule I. Here’s how that happened and what it means for you.
DEA final order, Apr 28 2026 · hearing paused Sep 29 · GAO report, Sep 23 · Gibson Dunn · Foley · Vicente
If you heard "weed got rescheduled" this year and figured that meant all of it, you're not alone. Here's the real deal: right now in New Jersey, the medical weed and the rec weed sitting in the same dispensary are treated completely differently by the federal government.
What actually happened
On April 28, 2026, the DEA moved two things from Schedule I to Schedule III:
- Marijuana in FDA-approved drugs
- Marijuana sold under a state medical marijuana license
That's it. Adult-use (rec) weed stayed in Schedule I, the same category as heroin. So did unlicensed weed and synthetic stuff like delta-10.
A separate DEA hearing started June 29 to decide whether all marijuana should move to Schedule III. That's the one that matters for rec.
And now it's on pause
On September 29, the DEA judge running that hearing paused it. A federal watchdog report (from the GAO) came out September 23 saying the DEA and FDA don't have written procedures for how they make scheduling decisions. Opponents of rescheduling jumped on that and asked for it to be added to the record.
The report itself never said rescheduling weed was wrong, and the pause doesn't undo the April changes for medical. But there's no end date on the pause. Responses are due October 13, so that's the next date to watch.
Why NJ is a weird case
A lot of NJ companies hold both medical and rec licenses, and some stores sell both out of the same building. So you can have:
- A medical sale that's federally Schedule III
- A rec sale of basically the same flower that's federally Schedule I
Same plant, same shelf, two different federal laws.
The money part: 280E
This is where it gets real for businesses. There's a federal tax rule called 280E that says businesses selling Schedule I or II drugs can't deduct normal expenses like rent and payroll. That's been crushing cannabis companies for years.
Now, medical licensees are out from under 280E. Rec businesses are still stuck with it. And for stores that sell both? Lawyers are openly saying nobody knows yet how the IRS is going to handle that split.
Medical businesses also have to register with the DEA now, with yearly fees between $888 and $3,699.
What it means for you
- If you're a medical patient: your program is on a stronger federal footing than it's ever been. That's a reason to look at keeping your card active, especially if the medical side starts getting cheaper to run.
- If you buy rec: nothing changed for you federally. You're still buying a Schedule I drug in the eyes of the federal government.
- For the industry: expect companies to lean harder into their medical side, since that's where the tax break is.
I'll update this when the hearing picks back up. Right now the honest answer to "is weed rescheduled?" is: half of it.
Sources
Right of reply
This is an explainer built from the DEA’s order and public reporting. Nobody was contacted for it. If anything here is out of date, tell me and it gets corrected on the page.
How this was put together
Written October 5, 2026 from law firm summaries of the DEA’s April order and the paused hearing, linked at the bottom. Registration fees are as reported. None of this is legal or tax advice.